medical affairs Archives - Pharma Marketing Network

Home Tags Medical affairs

Physician reviewing patient treatment progression while evaluating second-line therapy options during a clinical care decision.

The Escalation Effect: Where Pharma’s Biggest Prescribing Decisions Really Happen

Donna Pacheco - July 9, 2026

Doctor reviewing AI-generated synthetic control arm clinical trial data on a transparent digital interface to evaluate evidence for pharmaceutical decision-making.

The In-Silico Sell: Can Pharma Convince Doctors to Trust AI-Generated Clinical...

Donna Pacheco - July 2, 2026

Pharmaceutical communications team analyzing clinical trial results as media, investors, and digital platforms react to a major clinical data announcement.

Every Trial Is a Media Event Now: Managing the Commercial Fallout...

Donna Pacheco - June 18, 2026

Pharmaceutical industry professionals networking at a medical congress with digital analytics and scientific engagement visuals illustrating a year-round congress strategy.

The Congress Effect: How Smart Brands Turn Medical Meetings into Year-Round...

Donna Pacheco - June 17, 2026

Strategic pharmaceutical launch planning showing healthcare experts, scientific collaboration, and market preparation activities before drug approval.

The Invisible Launch: How Blockbuster Brands Build Demand Before Approval

Donna Pacheco - June 16, 2026

Pharmaceutical evidence supply chain showing clinical data moving from research and publications to medical guidelines, healthcare professionals, and commercial market influence.

The Evidence Supply Chain: How Clinical Data Becomes Commercial Influence

Donna Pacheco - June 15, 2026

Discover how an adaptive pharma content strategy helps brands keep messaging aligned with evolving clinical evidence and safety updates.

The “Clinical Truth Gap”: Why Static Pharma Messaging Is Breaking Down

Donna Pacheco - May 18, 2026

The Medical Affairs Revolution: Why Scientific Engagement Is Becoming Pharma Marketing’s...

Donna Pacheco - March 16, 2026

A digital collage showing a clock, FDA headquarters, digital content interface, and pharmaceutical items symbolizing the urgency of real-time pharma content strategy.

FDA Real‑Time Review Era: What It Means for Pharma Content Strategy

Donna Pacheco - December 7, 2025

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Doctor and patient discussing treatment in a modern exam room with visual elements representing aligned healthcare professional and direct-to-consumer pharmaceutical communication.

The HCP-DTC Divide: Why Pharma’s Biggest Communication Failure Happens Inside the...

July 14, 2026

Healthcare professional supporting a long-term survivor after advanced cell and gene therapy, illustrating post-treatment patient engagement, survivorship care, and real-world evidence collection.

The Survivorship Funnel: Pharma’s Biggest Opportunity Begins After Treatment Ends

July 13, 2026

Young adult managing a chronic health condition using a smartphone to access digital healthcare resources, representing Gen Z pharma marketing, patient engagement, and trusted health communication.

The Gen Z Chronic Care Shift: Winning the Trust of Healthcare’s...

July 13, 2026